Sana Biotechnology, Inc. Common Stock (SANA) is a publicly traded Healthcare sector company. As of May 21, 2026, SANA trades at $3.11 with a market cap of $846.01M and a P/E ratio of -3.22. SANA moved +1.31% today. Year to date, SANA is -23.40%; over the trailing twelve months it is +48.80%. Its 52-week range spans $1.26 to $7.30. Analyst consensus is strong buy with an average price target of $10.17. Rallies surfaces SANA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own SANA include Duquesne Family. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sana Biotechnology, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $3.11 |
| Market Cap | $846.01M |
| P/E Ratio | -3.22 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.30 |
| 52-Week Low | $1.26 |
| Volume | 1.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-244.17M |
| Gross Margin | 0.00% |
7 analysts cover SANA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.17.